Literature DB >> 25016574

Both positive and negative effects on immune responses by expression of a second class II MHC molecule.

Peggy P Ni1, Yaming Wang1, Paul M Allen2.   

Abstract

It is perplexing why vertebrates express a limited number of major histocompatibility complex (MHC) molecules when theoretically, having a greater repertoire of MHC molecules would increase the number of epitopes presented, thereby enhancing thymic selection and T cell response to pathogens. It is possible that any positive effects would either be neutralized or outweighed by negative selection restricting the T cell repertoire. We hypothesize that the limit on MHC number is due to negative consequences arising from expressing additional MHC. We compared T cell responses between B6 mice (I-A(+)) and B6.E(+) mice (I-A(+), I-E(+)), the latter expressing a second class II MHC molecule, I-E(b), due to a monomorphic Eα(k) transgene that pairs with the endogenous I-Eβ(b) chain. First, the naive T cell Vβ repertoire was altered in B6.E(+) thymi and spleens, potentially mediating different outcomes in T cell reactivity. Although the B6 and B6.E(+) responses to hen egg-white lysozyme (HEL) protein immunization remained similar, other immune models yielded differences. For viral infection, the quality of the T cell response was subtly altered, with diminished production of certain cytokines by B6.E(+) CD4(+) T cells. In alloreactivity, the B6.E(+) T cell response was significantly dampened. Finally, we observed markedly enhanced susceptibility to experimental autoimmune encephalomyelitis (EAE) in B6.E(+) mice. This correlated with decreased percentages of nTreg cells, supporting the concept of Tregs exhibiting differential susceptibility to negative selection. Altogether, our data suggest that expressing an additional class II MHC can produce diverse effects, with more severe autoimmunity providing a compelling explanation for limiting the expression of MHC molecules.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alloreactivity; Autoimmunity; CD4(+) T cells; Class II MHC; Viral infection

Mesh:

Substances:

Year:  2014        PMID: 25016574      PMCID: PMC4157116          DOI: 10.1016/j.molimm.2014.06.024

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  67 in total

Review 1.  The MHC, disease and selection.

Authors:  John Trowsdale
Journal:  Immunol Lett       Date:  2011-01-22       Impact factor: 3.685

Review 2.  T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  J M Fletcher; S J Lalor; C M Sweeney; N Tubridy; K H G Mills
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

3.  Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells.

Authors:  Angela M Thornton; Patricia E Korty; Dat Q Tran; Elizabeth A Wohlfert; Patrick E Murray; Yasmine Belkaid; Ethan M Shevach
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

4.  Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.

Authors:  Donatella Ciuffreda; Denis Comte; Matthias Cavassini; Emiliano Giostra; Leo Bühler; Monika Perruchoud; Markus H Heim; Manuel Battegay; Daniel Genné; Beat Mulhaupt; Raffaele Malinverni; Carl Oneta; Enos Bernasconi; Martine Monnat; Andreas Cerny; Christian Chuard; Jan Borovicka; Gilles Mentha; Manuel Pascual; Jean-Jacques Gonvers; Giuseppe Pantaleo; Valérie Dutoit
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

5.  Induction of intestinal Th17 cells by segmented filamentous bacteria.

Authors:  Ivaylo I Ivanov; Koji Atarashi; Nicolas Manel; Eoin L Brodie; Tatsuichiro Shima; Ulas Karaoz; Dongguang Wei; Katherine C Goldfarb; Clark A Santee; Susan V Lynch; Takeshi Tanoue; Akemi Imaoka; Kikuji Itoh; Kiyoshi Takeda; Yoshinori Umesaki; Kenya Honda; Dan R Littman
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

6.  Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses.

Authors:  Courtney Dow; Carla Oseroff; Bjoern Peters; Courtney Nance-Sotelo; John Sidney; Michael Buchmeier; Alessandro Sette; Bianca R Mothé
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

7.  Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.

Authors:  Inge E A Flesch; Wai-Ping Woo; Yang Wang; Vijay Panchanathan; Yik-Chun Wong; Nicole L La Gruta; Tania Cukalac; David C Tscharke
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

8.  Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.

Authors:  Magnus Isaksson; Brita Ardesjö; Lars Rönnblom; Olle Kämpe; Hans Lassmann; Maija-Leena Eloranta; Anna Lobell
Journal:  Eur J Immunol       Date:  2009-10       Impact factor: 5.532

9.  Tracking epitope-specific T cells.

Authors:  James J Moon; H Hamlet Chu; Jason Hataye; Antonio J Pagán; Marion Pepper; James B McLachlan; Traci Zell; Marc K Jenkins
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

10.  Intraclonal competition limits the fate determination of regulatory T cells in the thymus.

Authors:  Jhoanne L Bautista; Chan-Wang J Lio; Stephanie K Lathrop; Katherine Forbush; Yuqiong Liang; Jingqin Luo; Alexander Y Rudensky; Chyi-Song Hsieh
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

View more
  3 in total

1.  Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression.

Authors:  Lucia Poncette; Xiaojing Chen; Felix Km Lorenz; Thomas Blankenstein
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

2.  Evidence that MHC I-E dampens thyroid autoantibodies and prevents spreading to a second thyroid autoantigen in I-A(k) NOD mice.

Authors:  A-N Pelletier; H A Aliesky; B Banuelos; G Chabot-Roy; B Rapoport; S Lesage; S M McLachlan
Journal:  Genes Immun       Date:  2015-03-26       Impact factor: 2.676

3.  Bone Marrow Mesenchymal Stem Cells Inhibit the Function of Dendritic Cells by Secreting Galectin-1.

Authors:  Yue Zhang; Xia-Hui Ge; Xue-Jun Guo; Si-Bin Guan; Xiao-Ming Li; Wen Gu; Wei-Guo Xu
Journal:  Biomed Res Int       Date:  2017-06-21       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.